Niffer, France

Thomas Isarno

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Xenon Pharmaceuticals Inc.. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Isarno. Retrieved from https://idiyas.com/inventor/thomas-isarno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Isarno

Introduction

Thomas Isarno is a notable inventor based in Niffer, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic methods for spiro-oxindole compounds. With a total of four patents to his name, Isarno's work is focused on addressing sodium channel-mediated diseases, which can have a profound impact on pain management.

Latest Patents

Isarno's latest patents include innovative synthetic methods for spiro-oxindole compounds. These inventions are directed towards preparing specific spiro-oxindole derivatives that are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. His research in this area highlights the potential for new therapeutic approaches in pain management.

Career Highlights

Throughout his career, Thomas Isarno has been associated with Xenon Pharmaceuticals Inc., where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to the advancement of drug development processes, particularly in the realm of pain management therapies.

Collaborations

Isarno has collaborated with several esteemed colleagues, including Jean-Jacques Alexandre Cadieux and Mikhail A Chafeev. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of research.

Conclusion

In summary, Thomas Isarno is a prominent inventor whose work in synthetic methods for spiro-oxindole compounds is paving the way for new treatments in pain management. His contributions to Xenon Pharmaceuticals Inc. and collaborations with fellow researchers underscore his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…